Johnson & Johnson MedTech‘s  Medical announced today that it initiated a study evaluating its Javelin coronary IVL catheter.

J&J’s new pivotal study in coronary artery disease, dubbed FORWARD CAD, will test a cardiac-focused version of the Javelin as ...

Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is safer and more effective ...

Her kindness, humor and thoughtfulness were very much appreciated by our family.” Waller has worked for Decatur Memorial Hospital since 2008 and was the DMH May Colleague of the Month in 2024. The ...

A fired White Howard University Hospital cardiac catheterization lab manager isn’t entitled to a trial on his Title VII race discrimination claims, because he offered no evidence for a reasonable jury ...

Despite projections of rapid growth, the outpatient migration of cardiology has not accelerated as expected — even as cardiology stands out as the fastest-growing ASC specialty, according to a 2022 ...

The acquisition is part of a wide consolidation of the health care industry as young doctors turn away from private practice ...

According to the latest report from the State Health and Human Services Department, there are now 422 measles cases across 19 ...

The coronary stent market in India has reached a crucial milestone, with a valuation of USD 843.8 million in 2023, reflecting a transformative shift in the country’s approach to cardiovascular ...

Redux (also called "fen-phen" in combination with phentermine), was sold in the 1990s until it was removed from the market in 1997 after valvular heart damage and pulmonary hypertension were found.

French Hospital Medical Center (FHMC) held a ribbon-cutting ceremony Friday afternoon to celebrate the opening of the new ...

I took the diet drug Redux in the late 1990s. It was pulled off the market due to correlated heart issues. I saw a cardiologist and learned that I had mild to moderate mitral stenosis with ...